1-11 of 11
Qin Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II Trial

Lei Wang, Mengting Sun, Jinyang Li, Linghong Wan, Yuting Tan, Shuoran Tian, Yongying Hou, Linyu Wu, Ziyi Peng, Xiao Hu, Qihua Zhang, Zening Huang, Mengyi Han, Shiyin Peng, Yuwei Pan, Yuanfeng Ren, Mengsi Zhang, Dongfeng Chen, Qin Liu, Xianfeng Li, Zhong-yi Qin, Junyv Xiang, Mengxia Li, Jianwu Zhu, Qiyue Chen, Huiyan Luo, Shunan Wang, Tao Wang, Fan Li, Xiu-wu Bian, Bin Wang
Journal: Clinical Cancer Research
Clin Cancer Res OF1–OF13.
https://doi.org/10.1158/1078-0432.CCR-24-2436
Published: 27 November 2024
View article titled, Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II Trial
Open the PDF for Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II Trial in another window
Includes: Supplementary data
Journal Articles

Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations

Curtis H. Kugel, III, Stephen M. Douglass, Marie R. Webster, Amanpreet Kaur, Qin Liu, Xiangfan Yin, Sarah A. Weiss, Farbod Darvishian, Rami N. Al-Rohil, Abibatou Ndoye, Reeti Behera, Gretchen M. Alicea, Brett L. Ecker, Mitchell Fane, Michael J. Allegrezza, Nikolaos Svoronos, Vinit Kumar, Daniel Y. Wang, Rajasekharan Somasundaram, Siwen Hu-Lieskovan, Alpaslan Ozgun, Meenhard Herlyn, Jose R. Conejo-Garcia, Dmitry Gabrilovich, Erica L. Stone, Theodore S. Nowicki, Jeffrey Sosman, Rajat Rai, Matteo S. Carlino, Georgina V. Long, Richard Marais, Antoni Ribas, Zeynep Eroglu, Michael A. Davies, Bastian Schilling, Dirk Schadendorf, Wei Xu, Ravi K. Amaravadi, Alexander M. Menzies, Jennifer L. McQuade, Douglas B. Johnson, Iman Osman, Ashani T. Weeraratna
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (21): 5347–5356.
https://doi.org/10.1158/1078-0432.CCR-18-1116
Published: 01 November 2018
View article titled, Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations
Open the PDF for Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations in another window
Includes: Supplementary data
Journal Articles

Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma

Gao Zhang, Lawrence W. Wu, Ilgen Mender, Michal Barzily-Rokni, Marc R. Hammond, Omotayo Ope, Chaoran Cheng, Themistoklis Vasilopoulos, Sergio Randell, Norah Sadek, Aurelie Beroard, Min Xiao, Tian Tian, Jiufeng Tan, Umar Saeed, Eric Sugarman, Clemens Krepler, Patricia Brafford, Katrin Sproesser, Sengottuvelan Murugan, Rajasekharan Somasundaram, Bradley Garman, Bradley Wubbenhorst, Jonathan Woo, Xiangfan Yin, Qin Liu, Dennie T. Frederick, Benchun Miao, Wei Xu, Giorgos C. Karakousis, Xiaowei Xu, Lynn M. Schuchter, Tara C. Mitchell, Lawrence N. Kwong, Ravi K. Amaravadi, Yiling Lu, Genevieve M. Boland, Zhi Wei, Katherine Nathanson, Utz Herbig, Gordon B. Mills, Keith T. Flaherty, Meenhard Herlyn, Jerry W. Shay
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (19): 4771–4784.
https://doi.org/10.1158/1078-0432.CCR-17-2773
Published: 01 October 2018
View article titled, Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma
Open the PDF for Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma in another window
Includes: Multimedia, Supplementary data
Journal Articles

Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody

George A. Dominguez, Thomas Condamine, Sridevi Mony, Ayumi Hashimoto, Fang Wang, Qin Liu, Andres Forero, Johanna Bendell, Robert Witt, Neil Hockstein, Prasanna Kumar, Dmitry I. Gabrilovich
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (12): 2942–2950.
https://doi.org/10.1158/1078-0432.CCR-16-1784
Published: 14 June 2017
View article titled, Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody
Open the PDF for Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody in another window
Includes: Supplementary data
Journal Articles

Personalized Preclinical Trials in BRAF Inhibitor–Resistant Patient-Derived Xenograft Models Identify Second-Line Combination Therapies

Clemens Krepler, Min Xiao, Katrin Sproesser, Patricia A. Brafford, Batool Shannan, Marilda Beqiri, Qin Liu, Wei Xu, Bradley Garman, Katherine L. Nathanson, Xiaowei Xu, Giorgos C. Karakousis, Gordon B. Mills, Yiling Lu, Tamer A. Ahmed, Poulikos I. Poulikakos, Giordano Caponigro, Markus Boehm, Malte Peters, Lynn M. Schuchter, Ashani T. Weeraratna, Meenhard Herlyn
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (7): 1592–1602.
https://doi.org/10.1158/1078-0432.CCR-15-1762
Published: 31 March 2016
View article titled, Personalized Preclinical Trials in BRAF Inhibitor–Resistant Patient-Derived Xenograft Models Identify Second-Line Combination Therapies
Open the PDF for Personalized Preclinical Trials in BRAF Inhibitor–Resistant Patient-Derived Xenograft Models Identify Second-Line Combination Therapies in another window
Includes: Supplementary data
Journal Articles

Targeted T-cell Therapy in Stage IV Breast Cancer: A Phase I Clinical Trial

Lawrence G. Lum, Archana Thakur, Zaid Al-Kadhimi, Gerald A. Colvin, Francis J. Cummings, Robert D. Legare, Don S. Dizon, Nicola Kouttab, Abby Maizel, William Colaiace, Qin Liu, Ritesh Rathore
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (10): 2305–2314.
https://doi.org/10.1158/1078-0432.CCR-14-2280
Published: 14 May 2015
View article titled, Targeted T-cell Therapy in Stage IV Breast Cancer: A Phase I Clinical Trial
Open the PDF for Targeted T-cell Therapy in Stage IV Breast Cancer: A Phase I Clinical Trial in another window
Includes: Supplementary data
Journal Articles

BRAF Inhibition Stimulates Melanoma-Associated Macrophages to Drive Tumor Growth

Tao Wang, Min Xiao, Yingbin Ge, Clemens Krepler, Eric Belser, Alfonso Lopez-Coral, Xiaowei Xu, Gao Zhang, Rikka Azuma, Qin Liu, Rui Liu, Ling Li, Ravi K. Amaravadi, Wei Xu, Giorgos Karakousis, Tara C. Gangadhar, Lynn M. Schuchter, Melissa Lieu, Sanika Khare, Molly B. Halloran, Meenhard Herlyn, Russel E. Kaufman
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (7): 1652–1664.
https://doi.org/10.1158/1078-0432.CCR-14-1554
Published: 31 March 2015
View article titled, BRAF Inhibition Stimulates Melanoma-Associated Macrophages to Drive Tumor Growth
Open the PDF for BRAF Inhibition Stimulates Melanoma-Associated Macrophages to Drive Tumor Growth in another window
Includes: Supplementary data
Journal Articles

Combination of Quantitative IMP3 and Tumor Stage: A New System to Predict Metastasis for Patients with Localized Renal Cell Carcinomas

Zhong Jiang, Peigou G. Chu, Bruce A. Woda, Qin Liu, K.C. Balaji, Kenneth L. Rock, Chin-Lee Wu
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (17): 5579–5584.
https://doi.org/10.1158/1078-0432.CCR-08-0504
Published: 02 September 2008
View article titled, Combination of Quantitative IMP3 and Tumor Stage: A New System to Predict Metastasis for Patients with Localized Renal Cell Carcinomas
Open the PDF for Combination of Quantitative IMP3 and Tumor Stage: A New System to Predict Metastasis for Patients with Localized Renal Cell Carcinomas in another window
Journal Articles

IMP3 Predicts Aggressive Superficial Urothelial Carcinoma of the Bladder

Lioudmila Sitnikova, Gary Mendese, Qin Liu, Bruce A. Woda, Di Lu, Karen Dresser, Sambit Mohanty, Kenneth L. Rock, Zhong Jiang
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (6): 1701–1706.
https://doi.org/10.1158/1078-0432.CCR-07-2039
Published: 17 March 2008
View article titled, IMP3 Predicts Aggressive Superficial Urothelial Carcinoma of the Bladder
Open the PDF for IMP3 Predicts Aggressive Superficial Urothelial Carcinoma of the Bladder in another window
Journal Articles

p66 Shc Tumor Levels Show a Strong Prognostic Correlation with Disease Outcome in Stage IIA Colon Cancer

Steven R. Grossman, Stephen Lyle, Murray B. Resnick, Edmond Sabo, Rosina T. Lis, Elizabeth Rosinha, Qin Liu, Chung-Cheng Hsieh, Gajanan Bhat, A. Raymond Frackelton, Jr., Laurie J. Hafer
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19): 5798–5804.
https://doi.org/10.1158/1078-0432.CCR-07-0073
Published: 01 October 2007
View article titled, p66 Shc Tumor Levels Show a Strong Prognostic Correlation with Disease Outcome in Stage IIA Colon Cancer
Open the PDF for p66 Shc Tumor Levels Show a Strong Prognostic Correlation with Disease Outcome in Stage IIA Colon Cancer in another window
Journal Articles

Autologous High-Killing Cytotoxic T Lymphocytes against Human Lung Cancer Are Induced Using Interleukin (IL)-1β, IL-2, IL-4, and IL-6: Possible Involvement of Dendritic Cells

Yasuo Saijo, Xin Hong, Masashi Tanaka, Ryushi Tazawa, Shu Qin Liu, Kaoru Saijo, Tadao Ohno, Kaoru Koike, Kazuhiro Ohkuda, Ken Satoh, Toshihiro Nukiwa
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (5): 1203–1209.
Published: 01 May 1999
View article titled, Autologous High-Killing Cytotoxic T Lymphocytes against Human Lung Cancer Are Induced Using Interleukin (IL)-1β, IL-2, IL-4, and IL-6: Possible Involvement of Dendritic Cells
Open the PDF for Autologous High-Killing Cytotoxic T Lymphocytes against Human Lung Cancer Are Induced Using Interleukin (IL)-1β, IL-2, IL-4, and IL-6: Possible Involvement of Dendritic Cells in another window